van Lent Anja U, Nagasawa Maho, van Loenen Marleen M, Schotte Remko, Schumacher Ton N M, Heemskerk Mirjam H M, Spits Hergen, Legrand Nicolas
Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
J Immunol. 2007 Oct 15;179(8):4959-68. doi: 10.4049/jimmunol.179.8.4959.
In vitro production of human T cells with known Ag specificity is of major clinical interest for immunotherapy against tumors and infections. We have performed TCRalphabeta gene transfer into human hemopoietic progenitors from postnatal thymus or umbilical cord blood, and subsequently cultured these precursors on OP9 stromal cells expressing the Notch human ligand Delta-like1. We report here that fully mature, functional T cells with controlled Ag specificity are obtained from such cultures. Using vectors encoding TCRalphabeta-chains directed against melanoma (MART-1), viral (CMV), and minor histocompatibility (HA-2) Ags, we show that the obtained Ag-specific T cells exert cytolytic activity against their cognate Ag and expand in vitro upon specific TCR stimulation. Therapeutic applications may arise from these results because they provide a way to produce large numbers of autologous mature Ag-specific T cells in vitro from undifferentiated hemopoietic progenitors.
体外产生具有已知抗原特异性的人T细胞对于针对肿瘤和感染的免疫治疗具有重要的临床意义。我们已将TCRαβ基因转入来自产后胸腺或脐带血的人造血祖细胞,随后在表达Notch人类配体Delta样1的OP9基质细胞上培养这些前体细胞。我们在此报告,从这种培养物中可获得具有可控抗原特异性的完全成熟、有功能的T细胞。使用编码针对黑色素瘤(MART-1)、病毒(CMV)和次要组织相容性(HA-2)抗原的TCRαβ链的载体,我们表明所获得的抗原特异性T细胞对其同源抗原发挥细胞溶解活性,并在特异性TCR刺激下在体外扩增。这些结果可能会带来治疗应用,因为它们提供了一种从未分化的造血祖细胞体外大量生产自体成熟抗原特异性T细胞的方法。